Contraceptives Market Share

  • Report ID: 4635
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Contraceptives Market Regional Analysis:

North American Market Forecast   

North America region is projected to account for more than 39.8% market share by 2035, due to growing contraceptive awareness and STD prevention efforts. In a research survey conducted in the United States in the year 2022, it has been observed that around 80% or over 3-quarter of reproductive age females reported that they would favor having the availability of OTC birth control pills without having a prescription for the same. Also, the presence of a large population is anticipated to propel market growth. Furthermore, the number of unintended pregnancies especially in the teenage group is anticipated to augment regional growth. As per the data from the Centers for Disease Control and Prevention, nearly 14% of women aged 15-49 used contraceptive pills in the U.S. to prevent the risk of unwanted pregnancy during 2017-2018. In addition, the growth in Sexually Transmitted Diseases (STDs) and rising government awareness programs to tackle the burgeoning population is anticipated to favor the sales of contraceptives in the region. Rising commercialization of contraceptives by major key players along with expanding disposable income of the population is expected to impetus the growth of the global contraceptives market in the North America region.

APAC Market Statistics

On the other hand, the market in the Asia Pacific region is also estimated to grow with a significant share and hold a notable market share. The major factors attributed to the growth of the market are the rising population and the increased number of babies born each year. Also, the increased prevalence of sexually transmitted diseases among the teenage population is anticipated to favor market growth in the region. Favorable government policies including ‘Hum Do Humare Do’ by the Indian government are also projected to generate noteworthy revenue.

Contraceptives Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of contraceptives is estimated at USD 23.12 billion.

The global contraceptives market size crossed USD 21.97 billion in 2025 and is likely to expand at a CAGR of around 5.8%, surpassing USD 38.61 billion revenue by 2035.

North America contraceptives market will secure around 39.8% share by 2035, driven by growing contraceptive awareness and STD prevention efforts.

Key players in the market include Novartis Pharmaceutical Corporation, Agile Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Piramal Group, Viatris Inc., Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos